文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

不孕及辅助生殖技术治疗对产后妇女死亡率的影响。

Influence of subfertility and assisted reproductive technology treatment on mortality of women after delivery.

机构信息

Department of Reproductive Endocrinology and Infertility, Mayo Clinic, Rochester, Minnesota; Atrium Health, Charlotte, North Carolina.

Biostatistics, Boston University SPH, Boston, Massachusetts.

出版信息

Fertil Steril. 2020 Mar;113(3):569-577.e1. doi: 10.1016/j.fertnstert.2019.10.007. Epub 2020 Feb 7.


DOI:10.1016/j.fertnstert.2019.10.007
PMID:32044090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7088468/
Abstract

OBJECTIVE: To compare incidence, risk factors, and etiology of women's deaths in fertile, subfertile, and undergoing assisted reproductive technology (ART) in the years after delivery. DESIGN: Retrospective cohort. SETTING: University hospital. PATIENT(S): Women who had delivered in Massachusetts. INTERVENTION(S): This study used data from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System linked to vital records, hospital stays, and the Massachusetts death file. Mortality of patients delivered from 2004-2013 was evaluated through 2015. The exposure groups, determined on the basis of the last delivery, were ART-treated (linked to Society for Assisted Reproductive Technology Clinic Outcome Reporting System), subfertile (no ART but with indicators of subfertility including birth certificate checkbox for fertility treatment, prior hospitalization for infertility [International Classification of Disease codes 9 628 or V23], and/or prior delivery with checkbox or ART), or fertile (neither ART nor subfertile). Numbers (per 100,000 women-years) and causes of death were obtained from the Massachusetts death file. MAIN OUTCOME MEASURE(S): Mortality of women after delivery in each of the three fertility groups and the most common etiology of death in each. RESULT(S): We included 483,547 women: 16,429 ART, 11,696 subfertile, and 455,422 fertile among whom there were 1,280 deaths with 21.1, 25.5, and 44.7 deaths, respectively, per 100,000 women-years. External causes (violence, accidents, and poisonings) were the most common reasons for death in the fertile group. Deaths occurred on average 46 months after delivery. When external causes of death were removed, there were 19.1, 17.0, and 25.6 deaths per 100,000 women-years and leading causes of death in all groups were cancer and circulatory problems. CONCLUSION(S): The study presents reassuring data that death rates within 5 years of delivery in ART-treated and subfertile women do not differ from those in fertile women.

摘要

目的:比较生育、不孕和接受辅助生殖技术(ART)后女性在产后年份的发病率、危险因素和病因。

设计:回顾性队列研究。

地点:大学医院。

患者:在马萨诸塞州分娩的妇女。

干预措施:本研究使用了来自辅助生殖技术协会临床结果报告系统的数据,并与生命记录、住院情况和马萨诸塞州死亡档案相关联。通过 2015 年评估了 2004-2013 年期间分娩的患者的死亡率。根据最后一次分娩确定的暴露组包括接受 ART 治疗的患者(与辅助生殖技术协会临床结果报告系统相关联)、不孕患者(未接受 ART,但有生育治疗的指标,包括出生证明生育治疗复选框、不孕住院[国际疾病分类代码 9628 或 V23]和/或以前的分娩伴有复选框或 ART)和生育能力正常的患者(既未接受 ART 治疗也未不孕)。从马萨诸塞州死亡档案中获得了每 10 万名妇女年的死亡人数和死因。

主要观察指标:三种生育组产后妇女的死亡率以及每种组别的最常见死因。

结果:我们纳入了 483547 名妇女:16429 名接受 ART 治疗、11696 名不孕和 455422 名生育能力正常,其中分别有 21.1、25.5 和 44.7 人/10 万妇女年死亡。外部原因(暴力、事故和中毒)是生育能力正常组死亡的最常见原因。死亡平均发生在分娩后 46 个月。当去除外部原因导致的死亡后,ART 治疗组、不孕组和生育能力正常组的死亡人数分别为 19.1、17.0 和 25.6 人/10 万妇女年,所有组别的主要死因都是癌症和循环系统问题。

结论:本研究提供了令人安心的数据,表明接受 ART 治疗和不孕的女性在产后 5 年内的死亡率与生育能力正常的女性没有差异。

相似文献

[1]
Influence of subfertility and assisted reproductive technology treatment on mortality of women after delivery.

Fertil Steril. 2020-2-7

[2]
Hospitalizations up to 8 years following delivery in assisted reproductive technology-treated and subfertile women.

Fertil Steril. 2022-3

[3]
Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Am J Obstet Gynecol. 2017-9

[4]
Perinatal outcomes associated with assisted reproductive technology: the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).

Fertil Steril. 2015-4

[5]
Hospitalization before and after delivery in fertile, subfertile, and ART-treated women.

J Assist Reprod Genet. 2019-8-14

[6]
Factors associated with increased odds of cesarean delivery in ART pregnancies.

Fertil Steril. 2018-8

[7]
Severe Maternal Morbidity and the Use of Assisted Reproductive Technology in Massachusetts.

Obstet Gynecol. 2016-3

[8]
Early Autism Spectrum Disorders in Children Born to Fertile, Subfertile, and ART-Treated Women.

Matern Child Health J. 2019-11

[9]
The effect of father's age in fertile, subfertile, and assisted reproductive technology pregnancies: a population based cohort study.

J Assist Reprod Genet. 2014-11

[10]
Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment.

Fertil Steril. 2015-6

引用本文的文献

[1]
Assisted Reproductive Technology or Infertility: What underlies adverse outcomes? Lessons from the Massachusetts Outcome Study of Assisted Reproductive Technology.

F S Rev. 2022-10

[2]
Long term all-cause and cardiovascular disease mortality among women who undergo fertility treatment.

Med J Aust. 2022-11-21

[3]
RUBIC (ReproUnion Biobank and Infertility Cohort): A binational clinical foundation to study risk factors, life course, and treatment of infertility and infertility-related morbidity.

Andrology. 2021-11

[4]
Optimizing the control group for evaluating ART outcomes: can outpatient claims data yield a better control group?

J Assist Reprod Genet. 2021-5

本文引用的文献

[1]
Infertility treatment and risk of severe maternal morbidity: a propensity score-matched cohort study.

CMAJ. 2019-2-4

[2]
Mortality in Women Treated With Assisted Reproductive Technology-Addressing the Healthy Patient Effect.

Am J Epidemiol. 2018-9-1

[3]
Infertile women who screen positive for depression are less likely to initiate fertility treatments.

Hum Reprod. 2017-3-1

[4]
Recent Increases in the U.S. Maternal Mortality Rate: Disentangling Trends From Measurement Issues.

Obstet Gynecol. 2016-9

[5]
Society for Assisted Reproductive Technology and assisted reproductive technology in the United States: a 2016 update.

Fertil Steril. 2016-6-11

[6]
Inequity between male and female coverage in state infertility laws.

Fertil Steril. 2016-6

[7]
Black-white differences in severe maternal morbidity and site of care.

Am J Obstet Gynecol. 2016-1

[8]
Experiences with maternal and perinatal death reviews in the UK--the MBRRACE-UK programme.

BJOG. 2014-9

[9]
The MOSART database: linking the SART CORS clinical database to the population-based Massachusetts PELL reproductive public health data system.

Matern Child Health J. 2014-11

[10]
Identifying women with indicators of subfertility in a statewide population database: operationalizing the missing link in assisted reproductive technology research.

Fertil Steril. 2013-11-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索